Annual Total Long Term Liabilities
$412.70 K
-$1.46 M-77.98%
01 December 2023
Summary:
Altamira Therapeutics annual total long term liabilities is currently $412.70 thousand, with the most recent change of -$1.46 million (-77.98%) on 01 December 2023. During the last 3 years, it has fallen by -$731.40 thousand (-63.93%). CYTO annual total long term liabilities is now -96.66% below its all-time high of $12.34 million, reached on 31 December 2016.CYTO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$523.00 K
-$655.00 K-55.60%
01 June 2024
Summary:
Altamira Therapeutics quarterly total long term liabilities is currently $523.00 thousand, with the most recent change of -$655.00 thousand (-55.60%) on 01 June 2024. Over the past year, it has dropped by -$2.44 million (-82.33%). CYTO quarterly long term liabilities is now -96.73% below its all-time high of $16.00 million, reached on 31 March 2017.CYTO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.0% | -82.3% |
| 3 y3 years | -63.9% | -16.8% |
| 5 y5 years | -75.6% | -48.8% |
CYTO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.0% | at low | -82.3% | at low |
| 5 y | 5 years | -78.0% | at low | -82.3% | at low |
| alltime | all time | -96.7% | +101.3% | -96.7% | +101.6% |
Altamira Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $523.00 K(-55.6%) |
| Dec 2023 | $412.70 K(-78.0%) | $1.18 M(-60.2%) |
| June 2023 | - | $2.96 M(+57.9%) |
| Dec 2022 | $1.87 M(+34.5%) | $1.87 M(+76.4%) |
| June 2022 | - | $1.06 M(-23.7%) |
| Dec 2021 | $1.39 M(+21.8%) | $1.39 M(+121.7%) |
| June 2021 | - | $628.50 K(-45.1%) |
| Dec 2020 | $1.14 M(+21.6%) | $1.14 M(+2.3%) |
| June 2020 | - | $1.12 M(+18.8%) |
| Dec 2019 | $941.20 K(-44.3%) | $941.20 K(-7.9%) |
| June 2019 | - | $1.02 M(-39.5%) |
| Dec 2018 | $1.69 M(-82.8%) | $1.69 M(-20.6%) |
| Sept 2018 | - | $2.13 M(+35.7%) |
| June 2018 | - | $1.57 M(-79.6%) |
| Mar 2018 | - | $7.70 M(-21.6%) |
| Dec 2017 | $9.82 M | $9.82 M(-21.0%) |
| Sept 2017 | - | $12.43 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $13.74 M(-14.2%) |
| Mar 2017 | - | $16.00 M(+29.8%) |
| Dec 2016 | $12.34 M(+540.9%) | $12.33 M(-11.0%) |
| Sept 2016 | - | $13.85 M(+427.5%) |
| June 2016 | - | $2.63 M(+15.4%) |
| Mar 2016 | - | $2.28 M(+18.2%) |
| Dec 2015 | $1.93 M(+7.5%) | $1.93 M(-10.3%) |
| Sept 2015 | - | $2.15 M(-1.9%) |
| June 2015 | - | $2.19 M(+8.2%) |
| Mar 2015 | - | $2.02 M(+13.0%) |
| Dec 2014 | $1.79 M(-105.4%) | $1.79 M(+78.4%) |
| Sept 2014 | - | $1.00 M(-16.6%) |
| June 2014 | - | $1.20 M(+58.9%) |
| Mar 2014 | - | $757.90 K(-102.3%) |
| Dec 2013 | -$33.06 M(<-9900.0%) | -$33.06 M |
| Dec 2012 | $265.80 K(+40.0%) | - |
| Dec 2011 | $189.80 K | - |
FAQ
- What is Altamira Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Altamira Therapeutics?
- What is Altamira Therapeutics annual total long term liabilities year-on-year change?
- What is Altamira Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly long term liabilities year-on-year change?
What is Altamira Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CYTO is $412.70 K
What is the all time high annual total long term liabilities for Altamira Therapeutics?
Altamira Therapeutics all-time high annual total long term liabilities is $12.34 M
What is Altamira Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CYTO annual total long term liabilities has changed by -$1.46 M (-77.98%)
What is Altamira Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CYTO is $523.00 K
What is the all time high quarterly long term liabilities for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly total long term liabilities is $16.00 M
What is Altamira Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CYTO quarterly total long term liabilities has changed by -$2.44 M (-82.33%)